Tag: Ingenia Therapeutics
Ingenia eyes USD42m IPO as first US company listing in Korea
Ingenia Therapeutics’ KRW60 billion (USD42.4 million) IPO to become first listing of a US-based company in Korea
English
Ingenia Therapeutics’ KRW60 billion (USD42.4 million) IPO to become first listing of a US-based company in Korea
Chris Parsons shares his reflections on the Indian legal market’s transformation from 2005 to 2025
Follow us on LinkedIn